Covaxin

Centre to soon approve Biological E's Corbevax as precaution dose for people above 18 years

If approved by the government, this would be the first time a booster dose of a COVID vaccine different from the one used for primary vaccination would be allowed in the country

Linking COVID-19 vaccine with Monkeypox: Busting the myths

The virus has been named Monkeypox because initially it was detected in a monkey

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre

Minister of State for Health Bharati Pravin Pawar said as on 19 July, 2022, a total of 200.34 crore COVID-19 vaccine doses have been administered to beneficiaries above 12 years of age in the country

200 crore vaccinations: How India under Narendra Modi scripted Covid success story

The country crossed a record 200 crore Covid-19 vaccinations on 17 July 2022 within barely 18 months of launching this exercise on 16 January last year

Over 57% seniors faced mental health issues during COVID-19, 59% say government managed pandemic well

The fear of COVID-19 infection was the most prevalent factor that contributed to the rising mental health concerns among seniors

Vaxxed to the max: A look at India's COVID vaccination drive that is set to overtake US, Europe and Canada combined

As per official data, a total of 1,96,24,21,213 doses have been administered so far across the country, which is set to cross the combined doses of the United States, Europe and Canada

Covaxin safe, well-tolerated in 2-18 years age-group, announces Bharat Biotech

The clinical trial conducted in the paediatric population between June 2021 to September 2021 has shown safety, less reactogenic, and robust immunogenicity

As COVID-19 cases rise, vaccines play vital role to prevent mass hospitalization, adverse outcomes

Vaccines play a crucial role in preventing infection, hospitalizations, and adverse outcomes which cause deaths

Germany to recognise Bharat Biotech's COVID-19 vaccine Covaxin for travel from 1 June

In November last year, the World Health Organisation recommended Emergency Use Listing (EUL) status for Covaxin

In 15-18 years age group, over 80% got first dose of COVID vaccine, says Mandaviya

India began inoculating those in the age group of 15-18 years from 3 January and so far 5.92 crore beneficiaries in this age group have been given the first dose